Is aspirin safe for patients with heart failure? - Wikidata - wikimedia - TriplyDB

Is aspirin safe for patients with heart failure?

Is aspirin safe for patients with heart failure?

http://www.wikidata.org/entity/Q36823330

about

Clinical trials update and cumulative meta-analyses from the American College of Cardiology: WATCH, SCD-HeFT, DINAMIT, CASINO, INSPIRE, STRATUS-US, RIO-Lipids and cardiac resynchronisation therapy in heart failure Intermediate but not low doses of aspirin can suppress angiotensin-converting enzyme inhibitor-induced cough Preventing atherosclerotic events with aspirin Combined aspirin/ACE inhibitor treatment for CHF Chronic aspirin is effective--if data are massaged sufficiently.Effect of aspirin on vasodilation to bradykinin and substance P in patients with heart failure treated with ACE inhibitor Clinical evidence of dose-dependent interaction between aspirin and angiotensin-converting enzyme inhibitors Antithrombotic therapy is associated with better survival in patients with severe heart failure and left ventricular systolic dysfunction (EPICAL study)Aspirin alters arterial function in patients with chronic heart failure treated with ACE inhibitors: a dose-mediated deleterious effect Chronic aspirin therapy for the prevention of cardiovascular events: a waste of time, or worse?Acute administration of diclofenac, but possibly not long term low dose aspirin, causes detrimental renal effects in heart failure patients treated with ACE-inhibitors Efficacy of antithrombotic therapy in chronic heart failure: the HELAS study Heart failure: Part II Update on the interaction between aspirin and angiotensin-converting enzyme inhibitors.Thromboembolism in heart failure: who should be treated?Interaction between cyclooxygenase and the renin-angiotensin-aldosterone system: rationale and clinical relevance.ACE inhibitors unmask incoordinate diastolic wall motion in restrictive left ventricular disease.Intracardiac thrombus formation in cardiac impairment: the role of anticoagulant therapy Neuroendocrine activation after myocardial infarction: causes and consequences.Is aspirin safe in heart failure? more data.Is aspirin safe for patients with heart failure?Science to practice in underserved communities: the effectiveness of school mental health programming.Prevalence of markers of heart failure in patients with atrial fibrillation and the effects of ximelagatran compared to warfarin on the incidence of morbid and fatal events: a report from the SPORTIF III and V trials.Renal effects of aspirin are clearly dose-dependent and are of clinical importance from a dose of 160 mg.Cyclooxygenase inhibition causes marked impairment of renal function in elderly subjects treated with diuretics and ACE-inhibitors.Clinical trials update: IMPROVEMENT-HF, COPERNICUS, MUSTIC, ASPECT-II, APRICOT and HEART.Baseline clinical characteristics of patients recruited into the assessment of treatment with lisinopril and survival study

P2860

Q28168872-2667B0EE-3118-4F3E-9E3C-2E18D9526D31 Q28174646-01B3C95F-8DA9-4AE6-96A3-8405BAB0A888 Q28192083-145C16FC-1E05-4402-B914-04CAD4D9C6D6 Q28192122-3B013A9A-2363-4B89-AFFB-FD753AD9D2B7 Q28192280-47AE252A-1552-4DD1-9CDF-261193CE8C9B Q28192376-4E9AE132-BF40-4076-B3CB-CCD31F8BD70E Q28193095-2917A220-19F1-452D-A4CE-61B7A3449243 Q28194101-F4467AB0-EC49-46D6-969B-3BBBE2B4111A Q28196412-E5E4A527-7A99-465C-AD00-D0909E781334 Q28196889-20635900-A46E-4AC3-A8E6-45D47F182FCF Q28210545-FBE799F2-A42C-4E19-AEFB-DC4506936C8B Q28218636-AFEA122D-C933-4E69-9086-7719A1B0B2F4 Q33708950-D070E988-48FA-41EB-8A3D-63E68458F1D6 Q33942871-3026F0F9-86F4-4934-8763-663DF977BCD2 Q34103002-8B460AA4-0130-4C25-8BCA-E3A26E929ABA Q35580134-CF05E555-0F4F-435D-85F5-0D86430259A4 Q36836874-44AB20EE-E113-4A7C-8C5F-E9DC5EE1637A Q38646824-E68C9363-4EAA-428C-8B29-142103F7BFD9 Q41284840-A54FE1A2-AC77-443F-A88C-494556DA85B8 Q42391951-C37D229F-3350-4EC6-B211-72D538590AB8 Q42392246-12E6E801-B7B1-439D-8571-087F6E73E5B5 Q44532104-0A71BBE7-F681-43FC-8B93-76DA2FD35AEB Q44760892-49A145F4-BBA6-41D9-ACC8-AA2E06593813 Q46365651-2601CD8B-1642-442A-81CA-30744660CC53 Q46755095-BE1CED05-6695-4996-A2AE-BAD7CDE487AB Q50668477-3D472E3B-80D5-49A2-9877-88CFF1E93DF9 Q57484894-983F5667-593E-4BC5-AE26-7726831DD7E5

P2860

Is aspirin safe for patients with heart failure?

http://www.wikidata.org/entity/Q36823330

description

1995 nî lūn-bûn

@nan

1995年の論文

@ja

1995年論文

@yue

1995年論文

@zh-hant

1995年論文

@zh-hk

1995年論文

@zh-mo

1995年論文

@zh-tw

1995年论文

@wuu

1995年论文

@zh

1995年论文

@zh-cn

name

Is aspirin safe for patients with heart failure?

@en

type

label

Is aspirin safe for patients with heart failure?

@en

prefLabel

Is aspirin safe for patients with heart failure?

@en

P1433

Q36823330-67E97C1A-0E92-4165-BB09-580284A5E208

P1476

Q36823330-C2053540-E390-4448-91E9-53D1BDA0220E

P2093

Q36823330-300A7EA3-B4C7-435F-B948-CE7380A58E90

Q36823330-38135A95-7345-46C7-9236-C2D039A59366

Q36823330-75A474C9-49EB-45D2-AD42-76524F5B1762

Q36823330-766F83BC-E723-496C-BE49-46FDF54335D9

Q36823330-98E9D184-831D-468B-B44A-BCD1341D5BD1

Q36823330-B3FB002C-BC28-41EE-88D5-5DDC79F0DDF4

Q36823330-D53A77DD-E768-4C91-BD73-F761B0FF9C08

P2860

Q36823330-07EB4F2B-BA46-40F7-ABB2-443578B8145C

Q36823330-29DA2A52-0BDB-45AE-9137-8DE7F7BA4F44

Q36823330-3F29B1BD-65B9-42A9-8E98-8E5DB29725B8

Q36823330-4B706401-6537-4032-ACB1-2B751C2A4733

Q36823330-5A1F2BA4-1C5A-45ED-8FFE-489660DBE9C6

Q36823330-609A2404-7804-4133-ACA1-65A362474337

Q36823330-644DF35B-F71A-4052-A8DB-C05898CD23A4

Q36823330-66B32C54-195C-41F7-968C-AF0D19C9F992

Q36823330-6D97FA20-CA57-4AEA-8B03-E73D235293CE

Q36823330-82D3536A-77A7-4056-9CEB-7786515F85EF

P304

Q36823330-A48B3EE7-01C6-47E4-9463-856574D8244E

P31

Q36823330-4E000F22-3C76-4B12-9A41-30A47484E198

P356

Q36823330-072DA8C9-F906-4A30-AD97-63342080E77F

P433

Q36823330-86F42DF2-13B0-4C98-922A-F695D68FEC62

P478

Q36823330-EA372C65-F159-421B-A65D-23AC9CE5F3F8

P50

Q36823330-106E2992-EBF9-4826-ACA5-D4B340E85BEB

Q36823330-7672FB6B-7253-4E17-BB5E-2562E765BECA

P577

Q36823330-D1C530B2-006B-45ED-BC6E-8F3156D3F3D0

P5875

Q36823330-E5F9481B-4CF4-434E-9714-343A8692AAB1

P698

Q36823330-58B5BC49-B623-4294-8D18-5439351142EA

P921

Q36823330-206D2F14-01A7-4251-A53A-46DA6DFE1577

Q36823330-A74F4A7B-37B5-497B-AF52-B9D0C4D82396

P932

Q36823330-4625313B-9A8C-48F7-B0AB-17A512B0FC97

P356

P1433

British heart journal

P1476

Is aspirin safe for patients with heart failure?

@en

P2093

C J Bulpitt

http://www.w3.org/2001/XMLSchema#string

C M Oakley

http://www.w3.org/2001/XMLSchema#string

C R Prentice

http://www.w3.org/2001/XMLSchema#string

G C Sutton

http://www.w3.org/2001/XMLSchema#string

I N Findlay

http://www.w3.org/2001/XMLSchema#string

P A Poole-Wilson

http://www.w3.org/2001/XMLSchema#string

R H Falk

http://www.w3.org/2001/XMLSchema#string

P2860

A randomized controlled trial of acetyl salicylic acid in the secondary prevention of mortality from myocardial infarction

Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. The Swedish Angina Pectoris Aspirin Trial (SAPAT) Group

ACE inhibitors for heart failure: a question of dose

Mortality in heart failure: clinical variables of prognostic value

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

Aspirin and bleeding peptic ulcers in the elderly.

Combining salicylate and enalapril in patients with coronary artery disease and heart failure.

Peripheral haemodynamic effects of inhibition of prostaglandin synthesis in congestive heart failure and interactions with captopril.

Effects of converting-enzyme inhibitors on the renin-angiotensin-aldosterone, bradykinin, and arachidonic acid-prostaglandin systems: correlation of chemical structure and biologic activity.

Aspirin and secondary mortality after myocardial infarction.

P304

215-219

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/HRT.74.3.215

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

74

http://www.w3.org/2001/XMLSchema#string

P50

P577

1995-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

15652128

http://www.w3.org/2001/XMLSchema#string

P698

7547012

http://www.w3.org/2001/XMLSchema#string

P921

P932

484008

http://www.w3.org/2001/XMLSchema#string